InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,842.00
(
-0.02%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
85.46
(
-1.21%
)
Bitcoin
57,405.48
(
2.79%
)
Post# of 20775
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Stately

Send PM Follow Ignore
Followers 9
Posts 733
Boards Moderated 0
Alias Born 06/26/2009

Stately

Re: None

Friday, 03/11/2016 10:35:19 AM

Friday, March 11, 2016 10:35:19 AM

Post# of 20775
Mystifying that there's no PR about this. Looks like the Phase II for cerebral amyloid angiopathy was successful. Not sure about the meaning of the multiple dates, but it seems maybe the research was submitted in October and published in February.

So, possible reasons for the absence of a PR:

1. Waiting for announcement of Phase III
2. Waiting for buyout offer from Pfizer
3. The best possible case, FA trial from Shire was successful and the company is entertaining competing bids from Pfizer and Shire...
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up